These results strongly suggest that inclusion into liposomes of a solubilized proteic tumour-associated cell-surface antigen can provide an immunogen as potent as viable tumour cells in inducing an antibody response, and that the solubilization method may be critical. The gene discussed is CD53; the disease is neoplasm.